Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice

SARS-CoV-2 is a newly identified member of the coronavirus family that has caused the Coronavirus disease 2019 (COVID-19) pandemic. This rapidly evolving and unrelenting SARS-CoV-2 has disrupted the lives and livelihoods of millions worldwide. As of 23 August 2021, a total of 211,373,303 COVID-19 ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Natalie Yan-Lin, Pang, Alexander Shao-Rong, Chow, Vincent T., Wang, De-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405719/
https://www.ncbi.nlm.nih.gov/pubmed/34465396
http://dx.doi.org/10.1186/s40779-021-00342-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405719/
https://www.ncbi.nlm.nih.gov/pubmed/34465396
http://dx.doi.org/10.1186/s40779-021-00342-3

Ejemplares similares